European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 1.12% to 1,433.84 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by pharmaceutical company Ascendis Pharma (ASND) and medical device maker EDAP TMS (EDAP), which climbed 7.6% and 6%, respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and semiconductor company Sequans Communications (SQNS), which rose 3.3% and 2.9%, respectively.
The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and internet advertising firm Criteo (CRTO), which dropped 2.8% and 1.8%, respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and accommodations booking site trivago (TRVG), which were down 1.7% and 0.5%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and cruise line operator Carnival (CUK), which advanced 5.9% and 3.1%, respectively. They were followed by software firm Endava (DAVA) and insurance company Prudential (PUK), which were up 3.2% and 1.9%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and biotech firm Trinity Biotech (TRIB), which lost 5.9% and 4.1%, respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Akari Therapeutics (AKTX), which fell 2.7% and 1.8%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。